celastrol has been researched along with Cranial Nerve II Injuries in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bekerman, V; Caprioli, J; Gu, L; Kwong, JM; Kyung, H; Piri, N; Yadegari, D | 1 |
1 other study(ies) available for celastrol and Cranial Nerve II Injuries
| Article | Year |
|---|---|
Celastrol supports survival of retinal ganglion cells injured by optic nerve crush.
Topics: Animals; Body Weight; Cell Count; Cell Survival; Disease Models, Animal; DNA-Binding Proteins; Down-Regulation; Heat Shock Transcription Factors; Heat-Shock Proteins; Heme Oxygenase (Decyclizing); HSP70 Heat-Shock Proteins; Nerve Crush; Neuroprotective Agents; Optic Nerve; Optic Nerve Injuries; Pentacyclic Triterpenes; Rats; Retinal Ganglion Cells; Transcription Factors; Triterpenes; Tumor Necrosis Factor-alpha | 2015 |